CAS 900573-88-8: JI-101
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | JI-101 REF: IN-DA00GU3UCAS: 900573-88-8 | 99% | To inquire | Wed 16 Apr 25 |
 | JI-101 REF: 54-BUP12152CAS: 900573-88-8 | 99.4% | 289.00 €~1,804.00 € | Thu 17 Apr 25 |
 | JI-101 REF: TM-T3476CAS: 900573-88-8 | 99.35% - 99.41% | 37.00 €~472.00 € | Wed 23 Apr 25 |
 | JI-101 REF: 3D-ALB57388CAS: 900573-88-8 | Min. 95% | To inquire | Wed 28 May 25 |
Ref: IN-DA00GU3U
| 50mg | 193.00 € | ||
| 100mg | 325.00 € |
Estimated delivery in United States, on Wednesday 16 Apr 2025
Ref: 54-BUP12152
| 25mg | 289.00 € | ||
| 50mg | 460.00 € | ||
| 100mg | 705.00 € | ||
| 200mg | 923.00 € | ||
| 500mg | 1,804.00 € |
Estimated delivery in United States, on Thursday 17 Apr 2025
JI-101
CAS:900573-88-8
JI-101 (CGI-1842) is an oral multi-kinase inhibitor that targets VEGFR-2, PDGFR-β, and EphB4.
Formula:
C22H20BrN5O2
Purity:
99.35% - 99.41%
Color and Shape:
Solid
Molecular weight:
466.33
- Inhibitors
- Tyrosine Kinase/Adaptors
- Ephrin Receptor
- VEGFR
- See more categories
- PDGFR
Ref: TM-T3476
| 1mg | 37.00 € | ||
| 5mg | 79.00 € | ||
| 10mg | 111.00 € | ||
| 25mg | 187.00 € | ||
| 50mg | 303.00 € | ||
| 100mg | 472.00 € | ||
| 1mL*10mM (DMSO) | 87.00 € |
Estimated delivery in United States, on Wednesday 23 Apr 2025
JI-101
CAS:900573-88-8
Please enquire for more information about JI-101 including the price, delivery time and more detailed …
Formula:
C22H20BrN5O2
Purity:
Min. 95%
Molecular weight:
466.33 g/mol
Ref: 3D-ALB57388
| 25mg | 877.00 € | ||
| 50mg | 1,321.00 € | ||
| 100mg | 1,838.00 € |
Estimated delivery in United States, on Wednesday 28 May 2025
